ANROAlto Neuroscience, Inc.
- Market cap
- $862.15M
- as of 2026-10-23
- Latest close
- $21.97
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2024-02-05
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Smith Nicholas ConradPRESIDENT AND CFO | Oct 2 | Oct 5 | M | 55,000 | $2.32 | $127,600 | 79,060 | No | Form 4 |
| Smith Nicholas ConradPRESIDENT AND CFO | Oct 2 | Oct 5 | M · derivative | 55,000 | $2.32 | $127,600 | 57,405 | No | Form 4 |
| Smith Nicholas ConradPRESIDENT AND CFO | Sep 30 | Oct 1 | M | 24,056 | $2.35 | $56,532 | 48,116 | No | Form 4 |
| Smith Nicholas ConradPRESIDENT AND CFO | Sep 30 | Oct 1 | S | 23,170 | $25.78 | Sale −$597,290 | 24,946 | No | Form 4 |
| Smith Nicholas ConradPRESIDENT AND CFO | Sep 30 | Oct 1 | S | 886 | $26.87 | Sale −$23,807 | 24,060 | No | Form 4 |
| Smith Nicholas ConradPRESIDENT AND CFO | Sep 30 | Oct 1 | M · derivative | 24,056 | $2.35 | $56,532 | 121,818 | No | Form 4 |
| Smith Nicholas ConradPRESIDENT AND CFO | Sep 29 | Oct 1 | M | 56,455 | $2.35 | $132,669 | 80,515 | No | Form 4 |
| Smith Nicholas ConradPRESIDENT AND CFO | Sep 29 | Oct 1 | M | 54,375 | $2.35 | $127,781 | 134,890 | No | Form 4 |
| Smith Nicholas ConradPRESIDENT AND CFO | Sep 29 | Oct 1 | S | 110,830 | $26.58 | Sale −$2,946,150 | 24,060 | No | Form 4 |
| Smith Nicholas ConradPRESIDENT AND CFO | Sep 29 | Oct 1 | M · derivative | 56,455 | $2.35 | $132,669 | 145,874 | No | Form 4 |
| Smith Nicholas ConradPRESIDENT AND CFO | Sep 29 | Oct 1 | M · derivative | 54,375 | $2.35 | $127,781 | 35,625 | No | Form 4 |
| Miller Andrew Craig | May 27 | May 29 | A · derivative | 26,000 | $20.44 | $531,440 | 26,000 | No | Form 4 |
| Etkin AmitPRESIDENT AND CEO | May 14 | May 15 | G | 400,000 | $0.00 | $0 | 833,949 | No | Form 4 |
| Dreyfus Andrew | May 12 | May 14 | A · derivative | 10,958 | $24.63 | $269,896 | 10,958 | No | Form 4 |
| Sanchez Ramiro | May 12 | May 14 | A · derivative | 10,958 | $24.63 | $269,896 | 10,958 | No | Form 4 |
| Cox Christopher Nixon | May 12 | May 14 | A · derivative | 10,958 | $24.63 | $269,896 | 10,958 | No | Form 4 |
| York Gwill | May 12 | May 14 | A · derivative | 10,958 | $24.63 | $269,896 | 10,958 | No | Form 4 |
| Manji Husseini | May 12 | May 14 | A · derivative | 10,958 | $24.63 | $269,896 | 10,958 | No | Form 4 |
| Etkin AmitPRESIDENT AND CEO | Mar 1 | Mar 3 | F | 6,227 | $19.69 | $122,610 | 1,233,949 | No | Form 4 |
| Smith Nicholas ConradCHIEF FINANCIAL OFFICER & CBO | Mar 1 | Mar 3 | F | 2,806 | $19.69 | $55,250 | 24,060 | No | Form 4 |
| Hanley Jr. Michael ConickCHIEF OPERATING OFFICER | Feb 11 | Feb 13 | A · derivative | 131,000 | $16.71 | $2,189,010 | 131,000 | No | Form 4 |
| Etkin AmitPRESIDENT AND CEO | Feb 11 | Feb 13 | A · derivative | 306,000 | $16.71 | $5,113,260 | 306,000 | No | Form 4 |
| Savitz AdamCHIEF MEDICAL OFFICER | Feb 11 | Feb 13 | A · derivative | 124,000 | $16.71 | $2,072,040 | 124,000 | No | Form 4 |
| Smith Nicholas ConradCHIEF FINANCIAL OFFICER & CBO | Feb 11 | Feb 13 | A · derivative | 200,000 | $16.71 | $3,342,000 | 200,000 | No | Form 4 |
| Sanchez Ramiro | Jan 2 | Jan 6 | A · derivative | 3,806 | $11.82 | $44,987 | 3,806 | No | Form 4 |
| Cox Christopher Nixon | Jan 2 | Jan 6 | A · derivative | 7,189 | $11.82 | $84,974 | 7,189 | No | Form 4 |
| York Gwill | Jan 2 | Jan 6 | A · derivative | 5,243 | $11.82 | $61,972 | 5,243 | No | Form 4 |
| Manji Husseini | Jan 2 | Jan 6 | A · derivative | 4,228 | $11.82 | $49,975 | 4,228 | No | Form 4 |
| Sanchez Ramiro | Aug 12, 2025 | Aug 14, 2025 | A · derivative | 30,574 | $3.18 | $97,225 | 30,574 | No | Form 4 |
| Sanchez Ramiro | Aug 12, 2025 | Aug 14, 2025 | A · derivative | 3,928 | $2.21 | $8,681 | 3,928 | No | Form 4 |
| Smith Nicholas ConradCHIEF FINANCIAL OFFICER & CBO | Jul 3, 2025 | Jul 8, 2025 | A · derivative | 44,962 | $2.35 | $105,661 | 44,962 | No | Form 4 |
| Smith Nicholas ConradCHIEF FINANCIAL OFFICER & CBO | Jul 3, 2025 | Jul 8, 2025 | D · derivative | 44,962 | $6.23 | $280,113 | not reported | No | Form 4 |
| Smith Nicholas ConradCHIEF FINANCIAL OFFICER & CBO | Jul 3, 2025 | Jul 8, 2025 | A · derivative | 33,833 | $2.35 | $79,508 | 33,833 | No | Form 4 |
| Smith Nicholas ConradCHIEF FINANCIAL OFFICER & CBO | Jul 3, 2025 | Jul 8, 2025 | D · derivative | 33,833 | $6.23 | $210,780 | not reported | No | Form 4 |
| Smith Nicholas ConradCHIEF FINANCIAL OFFICER & CBO | Jul 3, 2025 | Jul 8, 2025 | A · derivative | 202,329 | $2.35 | $475,473 | 202,329 | No | Form 4 |
| Smith Nicholas ConradCHIEF FINANCIAL OFFICER & CBO | Jul 3, 2025 | Jul 8, 2025 | D · derivative | 202,329 | $5.30 | $1,072,344 | not reported | No | Form 4 |
| Smith Nicholas ConradCHIEF FINANCIAL OFFICER & CBO | Jul 3, 2025 | Jul 8, 2025 | A · derivative | 90,000 | $2.35 | $211,500 | 90,000 | No | Form 4 |
| Smith Nicholas ConradCHIEF FINANCIAL OFFICER & CBO | Jul 3, 2025 | Jul 8, 2025 | D · derivative | 90,000 | $14.88 | $1,339,200 | not reported | No | Form 4 |
| Smith Nicholas ConradCHIEF FINANCIAL OFFICER & CBO | Jul 3, 2025 | Jul 8, 2025 | A · derivative | 135,000 | $2.35 | $317,250 | 135,000 | No | Form 4 |
| Smith Nicholas ConradCHIEF FINANCIAL OFFICER & CBO | Jul 3, 2025 | Jul 8, 2025 | D · derivative | 135,000 | $4.20 | $567,000 | not reported | No | Form 4 |
| Etkin AmitPRESIDENT AND CEO | Jul 3, 2025 | Jul 8, 2025 | A · derivative | 34,620 | $2.35 | $81,357 | 34,620 | No | Form 4 |
| Etkin AmitPRESIDENT AND CEO | Jul 3, 2025 | Jul 8, 2025 | D · derivative | 34,620 | $6.23 | $215,683 | not reported | No | Form 4 |
| Etkin AmitPRESIDENT AND CEO | Jul 3, 2025 | Jul 8, 2025 | A · derivative | 247,290 | $2.35 | $581,132 | 247,290 | No | Form 4 |
| Etkin AmitPRESIDENT AND CEO | Jul 3, 2025 | Jul 8, 2025 | D · derivative | 247,290 | $5.30 | $1,310,637 | not reported | No | Form 4 |
| Etkin AmitPRESIDENT AND CEO | Jul 3, 2025 | Jul 8, 2025 | A · derivative | 223,000 | $2.35 | $524,050 | 223,000 | No | Form 4 |
| Etkin AmitPRESIDENT AND CEO | Jul 3, 2025 | Jul 8, 2025 | D · derivative | 223,000 | $14.88 | $3,318,240 | not reported | No | Form 4 |
| Etkin AmitPRESIDENT AND CEO | Jul 3, 2025 | Jul 8, 2025 | A · derivative | 215,000 | $2.35 | $505,250 | 215,000 | No | Form 4 |
| Etkin AmitPRESIDENT AND CEO | Jul 3, 2025 | Jul 8, 2025 | D · derivative | 215,000 | $4.20 | $903,000 | not reported | No | Form 4 |
| Savitz AdamCHIEF MEDICAL OFFICER | Jul 3, 2025 | Jul 8, 2025 | A · derivative | 22,481 | $2.35 | $52,830 | 22,481 | No | Form 4 |
| Savitz AdamCHIEF MEDICAL OFFICER | Jul 3, 2025 | Jul 8, 2025 | D · derivative | 22,481 | $6.23 | $140,057 | not reported | No | Form 4 |
| Savitz AdamCHIEF MEDICAL OFFICER | Jul 3, 2025 | Jul 8, 2025 | A · derivative | 33,008 | $2.35 | $77,569 | 33,008 | No | Form 4 |
| Savitz AdamCHIEF MEDICAL OFFICER | Jul 3, 2025 | Jul 8, 2025 | D · derivative | 33,008 | $6.23 | $205,640 | not reported | No | Form 4 |
| Savitz AdamCHIEF MEDICAL OFFICER | Jul 3, 2025 | Jul 8, 2025 | A · derivative | 123,645 | $2.35 | $290,566 | 123,645 | No | Form 4 |
| Savitz AdamCHIEF MEDICAL OFFICER | Jul 3, 2025 | Jul 8, 2025 | D · derivative | 123,645 | $5.30 | $655,319 | not reported | No | Form 4 |
| Savitz AdamCHIEF MEDICAL OFFICER | Jul 3, 2025 | Jul 8, 2025 | A · derivative | 73,000 | $2.35 | $171,550 | 73,000 | No | Form 4 |
| Savitz AdamCHIEF MEDICAL OFFICER | Jul 3, 2025 | Jul 8, 2025 | D · derivative | 73,000 | $14.88 | $1,086,240 | not reported | No | Form 4 |
| Savitz AdamCHIEF MEDICAL OFFICER | Jul 3, 2025 | Jul 8, 2025 | A · derivative | 76,000 | $2.35 | $178,600 | 76,000 | No | Form 4 |
| Savitz AdamCHIEF MEDICAL OFFICER | Jul 3, 2025 | Jul 8, 2025 | D · derivative | 76,000 | $4.20 | $319,200 | not reported | No | Form 4 |
| Hanley Jr. Michael ConickCHIEF OPERATING OFFICER | Jul 3, 2025 | Jul 8, 2025 | A · derivative | 8,000 | $2.35 | $18,800 | 8,000 | No | Form 4 |
| Hanley Jr. Michael ConickCHIEF OPERATING OFFICER | Jul 3, 2025 | Jul 8, 2025 | D · derivative | 8,000 | $14.88 | $119,040 | not reported | No | Form 4 |
| Hanley Jr. Michael ConickCHIEF OPERATING OFFICER | Jul 3, 2025 | Jul 8, 2025 | A · derivative | 188,000 | $2.35 | $441,800 | 188,000 | No | Form 4 |
| Hanley Jr. Michael ConickCHIEF OPERATING OFFICER | Jul 3, 2025 | Jul 8, 2025 | D · derivative | 188,000 | $12.40 | $2,331,200 | not reported | No | Form 4 |
| Hanley Jr. Michael ConickCHIEF OPERATING OFFICER | Jul 3, 2025 | Jul 8, 2025 | A · derivative | 125,000 | $2.35 | $293,750 | 125,000 | No | Form 4 |
| Hanley Jr. Michael ConickCHIEF OPERATING OFFICER | Jul 3, 2025 | Jul 8, 2025 | D · derivative | 125,000 | $4.20 | $525,000 | not reported | No | Form 4 |
| York Gwill | May 13, 2025 | May 15, 2025 | A · derivative | 15,287 | $2.37 | $36,230 | 15,287 | No | Form 4 |
| Dreyfus Andrew | May 13, 2025 | May 15, 2025 | A · derivative | 15,287 | $2.37 | $36,230 | 15,287 | No | Form 4 |
| Cox Christopher Nixon | May 13, 2025 | May 15, 2025 | A · derivative | 15,287 | $2.37 | $36,230 | 15,287 | No | Form 4 |
| Manji Husseini | May 13, 2025 | May 15, 2025 | A · derivative | 15,287 | $2.37 | $36,230 | 15,287 | No | Form 4 |
| Etkin AmitPRESIDENT AND CEO | Feb 5, 2025 | Feb 7, 2025 | A · derivative | 215,000 | $4.20 | $903,000 | 215,000 | No | Form 4 |
| Savitz AdamCHIEF MEDICAL OFFICER | Feb 5, 2025 | Feb 7, 2025 | A · derivative | 76,000 | $4.20 | $319,200 | 76,000 | No | Form 4 |
| Smith Nicholas ConradCHIEF FINANCIAL OFFICER & CBO | Feb 5, 2025 | Feb 7, 2025 | A · derivative | 135,000 | $4.20 | $567,000 | 135,000 | No | Form 4 |
| Hanley Jr. Michael ConickCHIEF OPERATING OFFICER | Feb 5, 2025 | Feb 7, 2025 | A · derivative | 125,000 | $4.20 | $525,000 | 125,000 | No | Form 4 |
| Cox Christopher Nixon | Jan 2, 2025 | Jan 6, 2025 | A · derivative | 25,236 | $3.17 | $79,998 | 25,236 | No | Form 4 |
| Manji Husseini | Jan 2, 2025 | Jan 6, 2025 | A · derivative | 14,195 | $3.17 | $44,998 | 14,195 | No | Form 4 |
| York Gwill | Jan 2, 2025 | Jan 6, 2025 | A · derivative | 19,558 | $3.17 | $61,999 | 19,558 | No | Form 4 |
| Savitz AdamCHIEF MEDICAL OFFICER | Jul 10, 2024 | Jul 11, 2024 | P | 2,931 | $13.22 | Purchase +$38,748 | 39,851 | No | Form 4 |
| Savitz AdamCHIEF MEDICAL OFFICER | Jul 9, 2024 | Jul 11, 2024 | P | 10,681 | $12.53 | Purchase +$133,833 | 35,532 | No | Form 4 |
| Savitz AdamCHIEF MEDICAL OFFICER | Jul 9, 2024 | Jul 11, 2024 | P | 1,388 | $13.15 | Purchase +$18,252 | 36,920 | No | Form 4 |
| Hanley Jr. Michael ConickChief Operating Officer | May 20, 2024 | May 22, 2024 | A · derivative | 188,000 | $12.40 | $2,331,200 | 188,000 | No | Form 4 |
| Smith Nicholas ConradCHIEF FINANCIAL OFFICER | Mar 28, 2024 | Apr 1, 2024 | P | 1,600 | $15.80 | Purchase +$25,280 | 22,316 | No | Form 4 |
| Smith Nicholas ConradCHIEF FINANCIAL OFFICER | Mar 28, 2024 | Apr 1, 2024 | P | 4,550 | $16.56 | Purchase +$75,348 | 26,866 | No | Form 4 |
| Radhakrishnan Maha | Mar 8, 2024 | Mar 12, 2024 | A · derivative | 30,574 | $13.76 | $420,698 | 30,574 | No | Form 4 |
| Radhakrishnan Maha | Mar 8, 2024 | Mar 12, 2024 | A · derivative | 1,590 | $10.21 | $16,234 | 1,590 | No | Form 4 |
| Apeiron Investment Group Ltd. | Feb 6, 2024 | Mar 6, 2024 | C | 251,881 | not reported | not reported | 251,881 | No | Form 4 |
| Apeiron Investment Group Ltd. | Feb 6, 2024 | Mar 6, 2024 | C | 674,658 | not reported | not reported | 674,658 | No | Form 4 |
| Apeiron Investment Group Ltd. | Feb 6, 2024 | Mar 6, 2024 | C · derivative | 444,561 | not reported | not reported | not reported | No | Form 4 |
| Apeiron Investment Group Ltd. | Feb 6, 2024 | Mar 6, 2024 | C · derivative | 406,072 | not reported | not reported | not reported | No | Form 4 |
| Apeiron Investment Group Ltd. | Feb 6, 2024 | Mar 6, 2024 | C · derivative | 1,063,918 | not reported | not reported | not reported | No | Form 4 |
| Apeiron Investment Group Ltd. | Feb 6, 2024 | Mar 6, 2024 | C · derivative | 416,665 | not reported | not reported | not reported | No | Form 4 |
| Etkin AmitPRESIDENT AND CEO | Mar 1, 2024 | Mar 5, 2024 | A | 34,711 | $0.00 | $0 | 1,240,176 | No | Form 4 |
| Etkin AmitPRESIDENT AND CEO | Mar 1, 2024 | Mar 5, 2024 | A · derivative | 223,000 | $14.88 | $3,318,240 | 223,000 | No | Form 4 |
| Smith Nicholas ConradCHIEF FINANCIAL OFFICER | Mar 1, 2024 | Mar 5, 2024 | A | 19,153 | $0.00 | $0 | 20,716 | No | Form 4 |
| Smith Nicholas ConradCHIEF FINANCIAL OFFICER | Mar 1, 2024 | Mar 5, 2024 | A · derivative | 90,000 | $14.88 | $1,339,200 | 90,000 | No | Form 4 |
| Savitz AdamCHIEF MEDICAL OFFICER | Mar 1, 2024 | Mar 5, 2024 | A · derivative | 73,000 | $14.88 | $1,086,240 | 73,000 | No | Form 4 |
| Alpha Wave Global, LP | Feb 6, 2024 | Feb 8, 2024 | C | 1,962,995 | not reported | not reported | 1,962,995 | No | Form 4 |
| Alpha Wave Global, LP | Feb 6, 2024 | Feb 8, 2024 | C | 1,144,762 | not reported | not reported | 3,107,757 | No | Form 4 |
| Alpha Wave Global, LP | Feb 6, 2024 | Feb 8, 2024 | P | 600,000 | $16.00 | Purchase +$9,600,000 | 3,707,757 | No | Form 4 |
| Alpha Wave Global, LP | Feb 6, 2024 | Feb 8, 2024 | C · derivative | 1,962,995 | $0.00 | $0 | not reported | No | Form 4 |
| Alpha Wave Global, LP | Feb 6, 2024 | Feb 8, 2024 | C · derivative | 1,144,763 | $0.00 | $0 | not reported | No | Form 4 |
| Chen Po Yu (Jeff) | Feb 6, 2024 | Feb 7, 2024 | C | 39,259 | not reported | not reported | 39,259 | No | Form 4 |
| Chen Po Yu (Jeff) | Feb 6, 2024 | Feb 7, 2024 | C | 8,450 | not reported | not reported | 47,709 | No | Form 4 |
| Chen Po Yu (Jeff) | Feb 6, 2024 | Feb 7, 2024 | C · derivative | 83,333 | $0.00 | $0 | not reported | No | Form 4 |
| Chen Po Yu (Jeff) | Feb 6, 2024 | Feb 7, 2024 | C · derivative | 18,794 | $0.00 | $0 | not reported | No | Form 4 |
| Etkin AmitPRESIDENT AND CEO | Feb 6, 2024 | Feb 7, 2024 | C | 11,777 | not reported | not reported | 1,202,340 | No | Form 4 |
| Etkin AmitPRESIDENT AND CEO | Feb 6, 2024 | Feb 7, 2024 | P | 3,125 | $16.00 | Purchase +$50,000 | 1,205,465 | No | Form 4 |
| Etkin AmitPRESIDENT AND CEO | Feb 6, 2024 | Feb 7, 2024 | C · derivative | 25,000 | $0.00 | $0 | not reported | No | Form 4 |
| Savitz AdamCHIEF MEDICAL OFFICER | Feb 6, 2024 | Feb 7, 2024 | C | 7,851 | not reported | not reported | 7,851 | No | Form 4 |
| Savitz AdamCHIEF MEDICAL OFFICER | Feb 6, 2024 | Feb 7, 2024 | P | 17,000 | $16.00 | Purchase +$272,000 | 24,851 | No | Form 4 |
| Savitz AdamCHIEF MEDICAL OFFICER | Feb 6, 2024 | Feb 7, 2024 | C · derivative | 16,666 | $0.00 | $0 | not reported | No | Form 4 |
| Cox Christopher Nixon | Feb 6, 2024 | Feb 7, 2024 | C | 588,898 | not reported | not reported | 588,898 | No | Form 4 |
| Cox Christopher Nixon | Feb 6, 2024 | Feb 7, 2024 | C | 126,755 | not reported | not reported | 715,653 | No | Form 4 |
| Cox Christopher Nixon | Feb 6, 2024 | Feb 7, 2024 | C · derivative | 1,250,000 | $0.00 | $0 | not reported | No | Form 4 |
| Cox Christopher Nixon | Feb 6, 2024 | Feb 7, 2024 | C · derivative | 281,917 | $0.00 | $0 | not reported | No | Form 4 |
| Smith Nicholas ConradCHIEF FINANCIAL OFFICER | Feb 6, 2024 | Feb 7, 2024 | P | 1,563 | $16.00 | Purchase +$25,008 | 1,563 | No | Form 4 |
| York Gwill | Feb 6, 2024 | Feb 7, 2024 | C | 23,917 | not reported | not reported | 23,917 | No | Form 4 |
| York Gwill | Feb 6, 2024 | Feb 7, 2024 | C · derivative | 53,196 | $0.00 | $0 | not reported | No | Form 4 |
| Dreyfus Andrew | Feb 1, 2024 | Feb 5, 2024 | A · derivative | 30,574 | $16.00 | $489,184 | 30,574 | No | Form 4 |
| Cox Christopher Nixon | Feb 1, 2024 | Feb 5, 2024 | A · derivative | 30,574 | $16.00 | $489,184 | 30,574 | No | Form 4 |
| Cox Christopher Nixon | Feb 1, 2024 | Feb 5, 2024 | A · derivative | 4,623 | $11.88 | $54,921 | 4,623 | No | Form 4 |
| Chen Po Yu (Jeff) | Feb 1, 2024 | Feb 5, 2024 | A · derivative | 30,574 | $16.00 | $489,184 | 30,574 | No | Form 4 |
| Chen Po Yu (Jeff) | Feb 1, 2024 | Feb 5, 2024 | A · derivative | 1,540 | $11.88 | $18,295 | 1,540 | No | Form 4 |
| Manji Husseini | Feb 1, 2024 | Feb 5, 2024 | A · derivative | 30,574 | $16.00 | $489,184 | 30,574 | No | Form 4 |
| Manji Husseini | Feb 1, 2024 | Feb 5, 2024 | A · derivative | 3,083 | $11.88 | $36,626 | 3,083 | No | Form 4 |
| York Gwill | Feb 1, 2024 | Feb 5, 2024 | A · derivative | 30,574 | $16.00 | $489,184 | 30,574 | No | Form 4 |
| York Gwill | Feb 1, 2024 | Feb 5, 2024 | A · derivative | 3,083 | $11.88 | $36,626 | 3,083 | No | Form 4 |